Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Marker composition for diagnosing or predicting prognosis of lung cancer based on exosome overexpressing GCC2 gene or protein

US Patent 12000832 · Granted Jun 4, 2024

Assignee

Inventors

View full patent text on Google Patents →